We illustrate a rare case of coexisting extramedullary manifestation of CMML and new onset follicular lymphoma within the same core-needle biopsy of a lymph node. We discuss the differences between extramedullary hematopoiesis and extramedullary manifestation of myeloid neoplasms. We also highlight the importance of generous tissue sampling and thorough examination of nodal tissue in the setting of an established myeloid neoplasm to avoid missing rare but possible nodal involvement.
PatnaikMMTefferiA. Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am J Hematol. 2020;95:97‐115.
2.
BowenJMPerryAMQuistEAkhtariM. Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia. Case Rep Pathol. 2015;2015:594970.
MathewRABennettJMLiuJJ, et al.Cutaneous manifestations in CMML: indication of disease acceleration or transformation to AML and review of the literature. Leuk Res. 2012;36:72‐80.
5.
HoverstenKVallapureddyRLashoT, et al.Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates. Leuk Lymphoma. 2018;59:2998‐3001.
6.
WilsonCSMedeirosLJ. Extramedullary manifestations of myeloid neoplasms. Am J Clin Pathol. 2015;144:219‐239.
7.
LiMMDattoMDuncavageEJ, et al.Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American society of clinical oncology, and college of American pathologists. J Mol Diagn. 2017;19:4‐23.
8.
StarrAGJonnaSRChahineJJKallakuryBVUjjaniCS. Concurrent diagnosis of chronic myeloid leukemia and follicular lymphoma: an unreported presentation. Case Rep Hematol. 2018;2018:7493601.
9.
HauckGJonigkDKreipeHHusseinK. Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms. Acta Haematol. 2013;129:187‐196.
10.
LaurentiLTarnaniMNicheleI, et al.The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol. 2011;86:1007‐1012.
11.
FlorensaLVallespiTWoessnerS, et al.Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes. Leuk Lymphoma. 1996;23:609‐612.
12.
PajorLKereskaiLTamaskaPVassJARadvanyiG. Coexistence of chronic myeloid leukemia and hairy cell leukemia of common clonal origin. Cancer Genet Cytogenet. 2002;134:114‐117.
13.
O’KeaneJCWolfBCNeimanRS. The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma. Cancer. 1989;63:1539‐1543.
14.
WolfBCNeimanRS. Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol. 1987;1:77‐80.
15.
YamamotoKMiwaYAbe-SuzukiS,et al.Extramedullary hematopoiesis: elucidating the function of the hematopoietic stem cell niche (review). Mol Med Rep. 2016;13:587‐591.
16.
KochCALiCYMesaRATefferiA. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78:1223‐1233.
17.
EASAtaFChoudryH,et al.Extramedullary haematopoiesis in patients with transfusion dependent beta-thalassaemia (TDT): a systematic review. Ann Med. 2022;54:764‐774.
18.
OguroHMcDonaldJGZhaoZUmetaniMShaulPW. Morrison SJ: 27-hydroxycholesterol induces hematopoietic stem cell mobilization and extramedullary hematopoiesis during pregnancy. J Clin Invest. 2017;127:3392‐3401.
19.
FanNLavuSHansonCATefferiA. Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: mayo clinic case series of 309 patients. Blood Cancer J. 2018;8:119.
20.
O’MalleyDP. Benign extramedullary myeloid proliferations. Mod Pathol. 2007;20:405‐415.
